Novozymes A S DKK 2.0
13F holders, Q2 2026 (June 30)4holders +1
1new positions
0sold out
$62.93avg. 13F price*
At the end of Q2 2026, 4 institutions reported holding Novozymes A S DKK 2.0 in their 13F filings, up 1 from Q1 2026. 1 opened new positions and 0 sold out. The largest holders were Delaney Dennis R ($456K), Elefante Mark B ($371K) and Somerville Kurt F ($204K).
- Company
- Novozymes A S DKK 2.0
- CUSIP
- B798FW902
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $201K |
| Exits | 0 | $0 |
All 13F filers, Q1 2026 → Q2 2026: 5,696 shares bought and 3,000 shares sold, net +2,696 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 4 holders
| Delaney Dennis R | 0.15% | Reduce -25.6% | 7,250 | $456K |
| Elefante Mark B | 0.16% | Add +73.5% | 5,900 | $371K |
| Somerville Kurt F | 0.05% | Reduce -13.4% | 3,240 | $204K |
| Hemenway Trust Co LLC | 0.01% | New | 3,196 | $201K |
"% of holder's portfolio" is NOVOZYMES A S DKK 2.0's weight in each manager's 13F, not the share of Novozymes A S DKK 2.0 the manager owns.